BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45
134 results:

  • 1. Treg-Related Genes Representing a Potential Shared Biological Mechanism Between Clear Cell Renal Carcinoma and Obesity.
    Zhou X; Li P; Xu Q; Ye J
    J Coll Physicians Surg Pak; 2024 Feb; 34(2):193-201. PubMed ID: 38342871
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Altered immune cell phenotypes within chronically ischemic human kidneys distal to occlusive renal artery disease.
    Zhu XY; Klomjit N; Pawar AS; Puranik AS; Yang ZZ; Lutgens E; Eirin A; Lerman A; Textor SC; Lerman LO
    Am J Physiol Renal Physiol; 2024 Feb; 326(2):F257-F264. PubMed ID: 38031731
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fibrin-Associated Large B-Cell Lymphoma (FA-LBCL) Involving Solid Organs as Necrotic Cystic Lesions-A Rare Entity with Potential Diagnostic Pitfalls: A Two-Case Series and Review of the Literature.
    Jia L; Xing C; Kandathil A; Rosado F; Chen W; Ramakrishnan Geethakumari P
    Int J Surg Pathol; 2024 May; 32(3):543-550. PubMed ID: 37461234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Japanese registry study and systematic review of particle therapy for renal cell carcinoma.
    Ishikawa H; Arimura T; Maruo K; Kawamura H; Toyama S; Ogino T; Okimoto T; Murakami M; Sato Y; Nishioka K; Araya M; Ohba H; Umehara K; Aoyama H; Obara W; Azuma H; Tsuji H; Sakurai H
    J Radiat Res; 2023 Jun; 64(Supplement_1):i41-i48. PubMed ID: 37045797
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Splenic surprise in a case of renal cell carcinoma: Unusual case or association?
    Agrawal T; Epari S; Prakash G; Menon S
    J Postgrad Med; 2023; 69(2):108-110. PubMed ID: 36891941
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
    Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
    Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Wan B; Yang Y; Zhang Z
    J Environ Public Health; 2023; 2023():8405945. PubMed ID: 36793506
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lymphangioleiomyomatosis (LAM) Cell Atlas.
    Du Y; Guo M; Wu Y; Wagner A; Perl AK; Wikenheiser-Brokamp K; Yu J; Gupta N; Kopras E; Krymskaya V; Obraztsova K; Tang Y; Kwiatkowski D; Henske EP; McCormack F; Xu Y
    Thorax; 2023 Jan; 78(1):85-87. PubMed ID: 36599466
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long-term outcomes of cryoablation for biopsy-proven T1 stage renal cell carcinoma.
    Song S; Yang Q; Gu C; Yu G; Hua B; Gu X; Wang L; Wang Z; Shi G; Xu B
    World J Surg Oncol; 2022 Sep; 20(1):284. PubMed ID: 36064369
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A systematic analysis of molecular mechanisms in non-metastatic renal cancer delineates affected regulatory pathways and genes in tumor growth.
    Xia R; Lin L; Yu S; Zhang J; Zheng L; Zhou L; Lin J
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):427-438. PubMed ID: 35818225
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CD20
    Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
    Front Immunol; 2022; 13():865596. PubMed ID: 35634306
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, cd45, CD48 and PD-1.
    Ziblat A; Iraolagoitia XLR; Nuñez SY; Torres NI; Secchiari F; Sierra JM; Spallanzani RG; Rovegno A; Secin FP; Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():681615. PubMed ID: 34149719
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
    Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
    Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Long-term follow-up of renal cell carcinomas T1a treated by percutaneous radiofrequency].
    Amadane N; André M; Daniel L; Coulange C; Baboudjian M; Michel F; Gondran-Tellier B; Vanacore D; Lechevallier E; Boissier R
    Prog Urol; 2021 Sep; 31(10):576-583. PubMed ID: 33593696
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics.
    Borcherding N; Vishwakarma A; Voigt AP; Bellizzi A; Kaplan J; Nepple K; Salem AK; Jenkins RW; Zakharia Y; Zhang W
    Commun Biol; 2021 Jan; 4(1):122. PubMed ID: 33504936
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Intravascular Large B-Cell Lymphoma and Renal Clear Cell Carcinoma as Collision Tumor: A Case Report and Review of the Literature.
    Serrano AG; Elsner B; Cabral Lorenzo MC; Morales Clavijo FA
    Int J Surg Pathol; 2021 Sep; 29(6):653-657. PubMed ID: 33345662
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression Analysis of Tyrosine Phosphatase Genes at Different Stages of Renal Cell Carcinoma.
    Laczmanska I; Laczmanski L; Sasiadek MM
    Anticancer Res; 2020 Oct; 40(10):5667-5671. PubMed ID: 32988891
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
    Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy.
    Theodros D; Murter BM; Sidhom JW; Nirschl TR; Clark DJ; Chen L; Tam AJ; Blosser RL; Schwen ZR; Johnson MH; Pierorazio PM; Zhang H; Ganguly S; Pardoll DM; Zarif JC
    Mol Cell Proteomics; 2020 Nov; 19(11):1850-1859. PubMed ID: 32737216
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.